Duluth MN 肺癌临床试验
11项针对 肺癌的研究正在 Duluth及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Essentia Health Cancer Center, Duluth
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
招募中3 期
- Essentia Health Cancer Center, Duluth
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Essentia Health Cancer Center, Duluth
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
招募中2 期
- MNCCTN Essentia Health Duluth, Duluth
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 以及另外 2 项
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
招募中3 期
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 以及另外 1 项
Integrated Cancer Repository for Cancer Research
招募中观察性研究欢迎健康志愿者
- Essentia Health - Duluth Clinic, Duluth
- St. Luke's Hospital of Duluth, Duluth
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Essentia Health Cancer Center, Duluth
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Essentia Health Cancer Center, Duluth
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Essentia Health Cancer Center, Duluth
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Duluth
其他城市的 肺癌试验
- Houston, TX78 项研究
- Boston, MA62 项研究
- New York City, NY60 项研究
- Los Angeles, CA45 项研究
- Washington, DC41 项研究
- Chicago, IL41 项研究
- Nashville, TN40 项研究
- Arlington, VA40 项研究
- Baltimore, MD40 项研究
- St. Louis, MO39 项研究
- Columbus, OH36 项研究
- Philadelphia, PA36 项研究
Duluth的其他研究
- 非小细胞肺癌13 项研究
- 乳腺癌7 项研究
- 前列腺癌7 项研究
- 急性髓系白血病6 项研究
- 结肠癌6 项研究
- 膀胱癌6 项研究
- 结直肠癌5 项研究
- 黑色素瘤5 项研究
- 喉癌5 项研究
- 食管癌5 项研究
- 直肠癌5 项研究
- 胃癌5 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月1日。每项研究自行设定入选标准,由研究团队决定谁能参与。